Charles Piller Profile
Charles Piller

@cpiller

Followers
5,215
Following
625
Media
177
Statuses
3,878

Investigative reporter @sciencemagazine . Before: investigations for @statnews @sacbee_news @latimes . cpiller @charlespiller .com - Signal 510.469.7984 - open DMs.

San Francisco Bay Area
Joined February 2011
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@cpiller
Charles Piller
5 months
My latest investigation for @newsfromscience : Star neuroscientist Berislav Zlokovic of @KECKSchool_USC implicated in possible misconduct involving apparent data doctoring going back 25+ years. Includes science behind a stroke drug in major human trials 1/5
18
149
284
@cpiller
Charles Piller
2 years
Were two separate, major lines of Alzheimer’s research tainted by image fabrication, with far-reaching implications for the field? I take a deep look for @ScienceMagazine 🧵 1/11
110
1K
4K
@cpiller
Charles Piller
4 years
The inside story of how Trump’s Covid coordinator Deborah Birx undermined CDC and created a hospital data “debacle” with perilous implications. My latest investigation for @ScienceMagazine
35
982
1K
@cpiller
Charles Piller
2 years
My latest deep dive for @sciencemagazine : Botanist Steven Newmaster won scientific fame and business success with tests that purportedly showed herbal remedies didn’t contain the ingredients on their labels. Was it all based on fraud? 1/6
13
152
414
@cpiller
Charles Piller
11 months
Last year, I wrote about multiple instances of apparent image doctoring in a landmark Nature paper on Alzheimer’s. Here are some new developments of note – thread 1/4
6
84
359
@cpiller
Charles Piller
2 years
Neuroscientist @schrag_matthew discovered >150 technical images/data by scientists linked to $sava (incl its drug Simufilam) that showed signs of improper manipulation. In my story, he outs himself as a whistleblower to @US_FDA and @NIH 2/11
8
44
336
@cpiller
Charles Piller
2 years
Following my investigation into her work with @Lsylvain , Karen Ashe says her own Nature paper should be retracted. My investigation here:
10
83
312
@cpiller
Charles Piller
3 years
Updated: This article now includes a link to one of several crucial, previously unpublished CDC reports used in my reporting that evaluates HHS Protect hospital data -- showing many causes for concern. See for yourself.
@cpiller
Charles Piller
3 years
My latest story, based on leaked documents, reveals a COVID-19 imperative for Biden: to aid planning and response, he must fix the dangerously dysfunctional HHS Protect hospital data system, or return the responsibility to CDC.
11
125
216
4
128
302
@cpiller
Charles Piller
2 years
Leading Alzheimer’s experts fear the @Lsylvain work (particularly the @Nature study) has steered boatloads of NIH and pharma $ down wrong paths 10/11
5
44
258
@cpiller
Charles Piller
4 years
France no longer allows HCQ as Covid-19 treatment, @nytimes reports. Quite a hit to the credibility of French researcher Didier Raoult -- whose suspect trial led to worldwide craze, and likely many needless deaths.
10
79
234
@cpiller
Charles Piller
6 months
My latest: Long-awaited CUNY investigation finds that Hoau-Yan Wang, a key scientist behind Cassava Sciences’ Alzheimer’s drug, engaged in “longstanding and egregious misconduct” associated with studies supporting the drug, simufilam. 1/3
35
90
242
@cpiller
Charles Piller
2 years
So far 7 suspect $sava papers have been retracted. Two @Lsylvain papers have been corrected; the correx show new signs of doctoring. Many others in both groups are under investigation by journals and universities 9/11
3
28
219
@cpiller
Charles Piller
3 years
My latest story, based on leaked documents, reveals a COVID-19 imperative for Biden: to aid planning and response, he must fix the dangerously dysfunctional HHS Protect hospital data system, or return the responsibility to CDC.
11
125
216
@cpiller
Charles Piller
2 years
NEW and unrelated to $sava, Schrag found >70 apparently doctored images in work by @umnmedschool prof Sylvain Lesné - @Lsylvain - and colleagues, including leading Alzheimer’s scholar Karen Ashe 4/11
3
32
213
@cpiller
Charles Piller
2 years
I vetted Schrag’s findings with numerous top Alzheimer’s experts, plus forensic image specialists. Many were stunned by the apparently extreme manipulations in both the $sava-linked and @Lsylvain cases 8/11
4
24
210
@cpiller
Charles Piller
4 years
Sponsors of clinical trials must by law report the results. These 30 research orgs broke that law 100% of the time - Part of my larger investigation just out
12
150
209
@cpiller
Charles Piller
2 years
Just after I queried @Nature editors, they announced their own investigation 7/11
3
22
206
@cpiller
Charles Piller
2 years
This broadens earlier concerns about $sava -linked work reported by @joewalkerWSJ @davidamichaels @apoorva_nyc @praddenkeefe and others 3/11
1
14
194
@cpiller
Charles Piller
2 years
Huge doubts emerged on one of the most-cited basic science Alz papers this century, in @Nature – by @Lsylvain , Ashe et al. It purportedly was first to ID a specific substance in brain tissue (Aβ*56) that impairs memory 5/11
2
23
183
@cpiller
Charles Piller
6 years
Hidden conflicts in #FDA drug approvals? My deep dive for @sciencemagazine : pharma $ to FDA advisors – before and after advisory meetings that recommended drug approvals. “Pay-later conflicts of interest” have gone largely unnoticed & entirely unpoliced.
Tweet media one
11
150
184
@cpiller
Charles Piller
2 years
Even if Ashe knew nothing about apparent tampering, say leading scholars, she should have vetted the work better – “a major ethical lapse.” She and @Lsylvain declined to be interviewed 6/11
1
16
175
@cpiller
Charles Piller
4 years
My latest: Dangerous precedent - Former FDA leaders decry emergency authorization of malaria drugs for Covid-19 - “a step away from scientific rigor, to ... wishful thinking to frank political and economic motivations.”
5
77
151
@cpiller
Charles Piller
5 months
This is a serious matter that is worth reading fully. @MicrobiomDigest is one of the most courageous and skilled forensic image analysts. I trust her work and rely on her incisive observations. The attacks on her are reprehensible.
@MicrobiomDigest
Elisabeth Bik
5 months
Male stock investor wants to sue a woman science critic because he thinks her reputation is dangerous. He wants me to stop and stripped of my PhD. Please tell @mattNachtrab what you think of his plan to sue me - for being regarded an expert, I guess?
107
155
1K
26
37
158
@cpiller
Charles Piller
1 year
My latest: Second death linked to lecanemab - heralded potential antibody treatment for Alzheimer’s disease. Heightens safety concerns
18
60
144
@cpiller
Charles Piller
6 months
I’m honored to be a winner of the National Academies/Schmidt Award for Excellence in Science Communications, for stories highlighting signs of misconduct in Alzheimer’s research thanks to courageous whistleblowers like @schrag_matthew #sciencejournalism @scicommexcellence
@NewsfromScience
News from Science
6 months
Congratulations to @cpiller , winner of an Eric and Wendy Schmidt Award for Excellence in Science Communications in the Science Journalist: Freelancer category. @SciCommAwards 🏆 Here’s a look at his winning stories. (THREAD 🧵)
Tweet media one
20
15
46
42
20
139
@cpiller
Charles Piller
4 years
Breaking - First major research scandal of COVID-19 era is a very painful one for all kinds of reasons: Two elite medical journals retract coronavirus papers over data integrity questions - my story:
9
83
109
@cpiller
Charles Piller
4 years
‘This is insane!’ Scientists lament Trump’s embrace of risky malaria drugs for coronavirus: My take on how a few words from the president based on one tiny study set off a perilous global trend
5
81
118
@cpiller
Charles Piller
1 year
my latest: Scientists tie third clinical trial death to experimental Alzheimer’s drug lecanemab - Amid lobbying for its approval by FDA, newly revealed death adds to doubts about safety of antiamyloid antibody
10
43
109
@cpiller
Charles Piller
11 months
I wonder why has Nature not yet retracted the article, many months after its editors posted a notice of concern? Why have the coauthors also stayed silent? 4/4
6
15
100
@cpiller
Charles Piller
5 years
Is #prediabetes a Dubious Diagnosis? @CDCgov says 1/3 of adults have it. My investigation shows prediabetes began as @AmDiabetesAssn marketing pitch. A borderline test result was medicalized to create tens of millions of new patients.
4
69
101
@cpiller
Charles Piller
3 years
Biden promised in 2016 to defund sponsors of medical experiments who flout the law the requires them to report results. Today, many are as bad as ever. Will the president now enforce the clinical trials law? My latest, for @nytimes
8
39
100
@cpiller
Charles Piller
3 years
ICYMI: Why the new coronavirus variant is such a worry -- a clear look at the alarmingly simple math behind the prospect of exponential growth in transmission. via @zeynep
Tweet media one
3
55
95
@cpiller
Charles Piller
5 months
Quick action by NIH after my investigation of studies by USC's Berislav Zlokovic: Agency puts hold on $30 million trial of potential stroke drug and launches its own probe of possible misconduct | Science | AAAS
6
29
80
@cpiller
Charles Piller
2 years
But I reveal that leading experts now say that paper and others were based on fraud. The whole effort to expose Newmaster was launched by his former student @Apex_Herbivore 4/6
2
7
72
@cpiller
Charles Piller
3 years
Warren Buffett's wealth contradictions go back a long way and well beyond his taxes. For example, my story:
1
9
67
@cpiller
Charles Piller
11 months
Actually, Ashe’s perplexing preprint does the opposite, as shown in this incisive analysis by @schrag_matthew – who detected the earlier apparent doctoring 3/4
2
5
66
@cpiller
Charles Piller
6 months
Correction is courageous | Scientists, like all humans, are fallible. Journals should manage corrections more efficiently to preserve and increase trust. via @hholdenthorp
20
20
68
@cpiller
Charles Piller
2 years
I show that much of Newmaster’s work is characterized by episode after episode of apparent plagiarism, fabulism, and data fabrication. A weird story, yet one strangely in sync with our times. 6/6
2
5
61
@cpiller
Charles Piller
4 years
My new deep dive for @sciencemagazine – as Covid vaccines/drugs are tested in hundreds of clinical trials, FDA oversight of trials is lax, slow, secretive. Enforcement has dropped sharply for years, and fallen off the cliff under Trump.
Tweet media one
1
46
63
@cpiller
Charles Piller
4 years
How does the Gates Foundation $$ influence news organizations? Important, deeply reported story by @TimothyWSchwab - Journalism’s Gates keepers via @cjr
1
27
50
@cpiller
Charles Piller
6 years
FDA revolving door open too wide? 11 of 16 #FDA medical examiners who worked on 28 drug approvals examined by @sciencemagazine , and then left the agency for new jobs, are now employed by or consult for the companies they recently regulated.
Tweet media one
5
49
46
@cpiller
Charles Piller
11 months
Recently, the senior author of that paper, Karen Ashe of the Univ of Minn, posted a preprint that purports to validate many of the paper’s questioned findings 2/4
1
5
49
@cpiller
Charles Piller
5 months
Financial Times opinion writer weighs in on my Zlokovic investigation and related matters - 'There is a scientific fraud epidemic — and we are ignoring the cure' via @ft @anjahuja
2
15
49
@cpiller
Charles Piller
2 years
Weekend reads: Harvard sued over retracted paper; 'retraction with honor'; critiquing our fake peer review coverage via @ivanoransky
0
24
45
@cpiller
Charles Piller
5 months
Among the people who worked tirelessly on the whistleblower dossier: @schrag_matthew @Thatsregrettab1 @MicrobiomDigest 5/5
6
4
44
@cpiller
Charles Piller
4 years
Trump on chloroquine and hydroxychloroquine: 'It couldn’t hurt to try." But as @VPrasadMDMPH and Ezekiel Emanuel point out, it often harms people and efforts to find real cure.
5
22
43
@cpiller
Charles Piller
2 years
BTW, now Newmaster is identifying cannabis species to help with industry quality control and works with COVID-19 testing companies. He outlandishly claimed to have been genetically sequencing SARS-CoV-2 in the summer and fall of 2019, months before the pandemic started. 5/6
1
3
37
@cpiller
Charles Piller
2 years
Thoughtful thread on some of the bigger picture questions on apparent image manipulation.
@VPrasadMDMPH
Vinay Prasad MD MPH
2 years
Brilliant article by @cpiller Smells like image tampering in key papers for Amyloid hypothesis It's likely just the TIP of the 🧊berg Think about it We can SEE the images For most papers, you don't 👀data A few thoughts on science 🧵
30
132
456
1
4
42
@cpiller
Charles Piller
3 years
For anyone looking for the links to my @sciencemagazine stories discussed tonight by @maddow and @Laurie_Garrett – about the harm caused by privatization of COVID hospital data by Trump Admin: and
2
29
40
@cpiller
Charles Piller
4 years
'We are prioritizing meds that cost $100,000 a year or more (while) loosening restrictions on environmental pollution. These policies have one thing in common: they enhance corporate profits.' More insights from @VPrasadMDMPH
1
19
38
@cpiller
Charles Piller
4 years
“FDA is a regulatory agency charged with protecting the public’s best interests. But at times it behaves like an attorney working on behalf of the companies.” - @VPrasadMDMPH in my probe of FDA's lax, slow, secretive oversight of clinical trials
Tweet media one
3
18
35
@cpiller
Charles Piller
4 years
Great overview of the challenges and doubts about these two widely-discussed Covid-19 antibody studies.
@stephaniemlee
Stephanie M. Lee
4 years
NEW: Two big antibody studies in California — Santa Clara and Los Angeles County — are making waves with their estimates that there are way more coronavirus infections than we thought. But scientists are skeptical, for LOTS of reasons. I dive into it all:
22
141
283
3
14
31
@cpiller
Charles Piller
2 years
Tweet media one
1
2
35
@cpiller
Charles Piller
1 year
Lecanemab patient dies of massive brain hemorrhage after a shattering and chaotic episode in the emergency department - What will Eisai and Biogen say about this second death associated with their experimental Alzheimer's treatment?
@cpiller
Charles Piller
1 year
My latest: Second death linked to lecanemab - heralded potential antibody treatment for Alzheimer’s disease. Heightens safety concerns
18
60
144
8
10
35
@cpiller
Charles Piller
2 years
This thread expands on a small point in my story about Steven Newmaster -- worth a look for anyone tracking Herbalife issues.
@theliverdr
TheLiverDoc
2 years
Twist in Tale 1/ 2018: I publish a report showng Herbalife caused death in young woman Early 2019: Herbalife unleashes legal, 'scientific' hell-storm on me, co-authors, journal, threatening us Mid 2019: Herbalife's concerns r scientifically rebutted...
Tweet media one
6
77
228
0
15
35
@cpiller
Charles Piller
6 months
The Saga of Cassava | Science | AAAS @Dereklowe sums up the Wang/CUNY/simufilam controversy in the wake of my article last week in @ScienceMagazine
24
8
34
@cpiller
Charles Piller
1 year
FDA might approve Alzheimer’s drug lecanemab by 1/6. Will it mandate “black box” warning that the drug+blood thinners can kill, as Eisai admitted in trial consent forms but not publicly. Skeptics: What else won't Eisai say? My story:
4
10
33
@cpiller
Charles Piller
2 years
Sheldon Krimsky, an intellectual hero of mine, Who Warned of Profit Motive in Science, Dies at 80. I'll never forget his generosity, integrity, and support early in my career.
0
6
32
@cpiller
Charles Piller
5 years
Read this thread. @MarkSZaidEsq has been fighting the good fight, without fear or favor, for a long time. Kinda like a good journalist does.
@MarkSZaidEsq
Mark S. Zaid
5 years
11/I also do or have represented many media outlets & reporters in #FOIA cases. They run spectrum of ideology & include: @DailyCaller , @MSNBC , @WSJ , @USATODAY , @thedailybeast & @politico . The goal is transparency. Obtain govt documents for public to review and assess.
4
99
626
2
11
27
@cpiller
Charles Piller
6 months
Whistleblower on Wang and Cassava’s studies, @schrag_matthew , called CUNY report “detailed, thorough, and credible.” He says “The phase 3 simufilam clinical trials should never have started. And they should certainly be shut down on the basis of this report.” 3/3
8
4
33
@cpiller
Charles Piller
6 months
The 50-page report obtained by Science says Wang failed to turn over to the panel “even a single datum or notebook in response to any allegation.” CUNY says action on the report is “imminent.” 2/3
2
2
33
@cpiller
Charles Piller
4 months
Another important expression of concern about a study by HY Wang of CUNY and other important researchers that was tagged in the CUNY investigation I wrote about recently. My earlier story with link to CUNY investigation:
21
14
32
@cpiller
Charles Piller
6 years
New real-time tracker Clinical Trial tracker shows which institutions are breaking the law. First results now up. An amazing tool for anyone concerned about evidence-based medicine. From @bengoldacre et al at Oxford
2
23
31
@cpiller
Charles Piller
2 years
It's a bizarre tale of how apparent misconduct—hiding in plain sight—skewed the herbal-supplement industry. 2/6
1
0
29
@cpiller
Charles Piller
1 year
My latest: Clinical trial participant’s autopsy and brain exam stoke Alzheimer’s drug fears – details on a lecanemab (Leqembi) death 1/3
3
13
31
@cpiller
Charles Piller
5 months
The Dark Side of a Clinical Trial | Science | AAAS @Dereklowe offers his take on my recent investigation of work by USC's Berislav Zlokovic
4
15
30
@cpiller
Charles Piller
5 months
A leading neuroscience expert after viewing the apparently doctored images: “I immediately felt nauseous…The integrity of the scientific record is so fundamental to what we do that seeing this kind of data anomaly is distressing.” 4/5
1
4
32
@cpiller
Charles Piller
6 years
Personal news: I am now working as an investigative correspondent for @sciencemagazine - and am honored to stay connected to my amazing colleagues at @statnews as a contributing writer.
1
5
29
@cpiller
Charles Piller
4 years
The three scientists at the heart of the Surgisphere COVID-19 scandal each left a trail of hints. Did @TheLancet and @NEJM exercise due diligence? You be the judge.
Tweet media one
Tweet media two
Tweet media three
4
21
28
@cpiller
Charles Piller
2 years
Newmaster pioneered using snippets of DNA to identify supplement ingredients. In 2013 he accused the industry of selling pills larded with inert fillers and tainted with toxic contaminants. Chastened, some big suppliers hired Newmaster to test their products. 3/6
1
2
26
@cpiller
Charles Piller
6 years
Are We Being Misled About Precision Medicine? - terrific @LizSzabo piece. With PM, few are helped, yet the price is stratospheric. Meanwhile, basic health services remain out of reach for millions. Is this a great country or what?
4
16
26
@cpiller
Charles Piller
2 years
Thanks to @megynkelly for thoughtful, probing questions about my recent Alzheimer's investigation in @NewsfromScience . Also excellent comments from @schrag_matthew
@MegynKellyShow
The Megyn Kelly Show
2 years
"Both of our jaws dropped at that moment. We both realized this was something of some great significance..." @cpiller  on how investigative journalism brought doctored images of Alzheimer's research to light. Watch & subscribe:
3
4
30
2
3
25
@cpiller
Charles Piller
5 months
Former lab members described a “toxic” lab culture & constant pressure to produce data consistent with Zlokovic’s ideas – even when experiments turned out differently. One said: “I started hating science. … It made me sick.” 3/5
1
4
28
@cpiller
Charles Piller
3 years
A Big Study About Honesty Turns Out To Be Based On Fake Data - another terrific @stephaniemlee story on scientific integrity
1
6
21
@cpiller
Charles Piller
3 years
'On the Media' interviewed me on the atrocious practices of medical researchers who fail to report the results of their clinical experiments. Thanks to @Bobosphere , Alex Hanesworth and @onthemedia for terrific questions
3
9
24
@cpiller
Charles Piller
4 years
Where’s the data? In a pandemic, now is no time to sit on remdesivir Covid-19 trial results via @pharmalot via @statnews
4
8
22
@cpiller
Charles Piller
3 years
Surgisphere’s revenge? Most scholarly articles that cite those infamous, disgraced, retracted COVID-19 papers fail to note that they were retracted. With insights from @esuelzer @ivanoransky My latest:
0
13
22
@cpiller
Charles Piller
5 months
Zlokovic, a top expert in stroke and Alzheimer’s has been a towering figure in the field. A 113-page whistleblower dossier suggests image manipulation to support his experimental hypotheses 2/5
1
3
23
@cpiller
Charles Piller
4 years
Double Dip: NIH program pays off $100K+++ in school debt to keep scientists in academia. Many break the rules by also taking industry money; other rules let them keep the cash without penalty. My investigation
Tweet media one
1
17
23
@cpiller
Charles Piller
6 years
Oakland California #hailstorm was intense. Lots of shredded plants.
Tweet media one
3
8
22
@cpiller
Charles Piller
3 years
As someone who has written investigative stories about the Gates Foundation (as as an @statnews alum who deeply respects that group's journalism), I think the @TimothyWSchwab thread is worth reading.
@TimothyWSchwab
Tim Schwab
3 years
1/ Months ago, I was asked to be a co-reporter on this story. I declined b/c the #GatesFoundation was a funder, which I knew would make it impossible to rigorously examine Gates's role in Covax. This story is a case study in the perils of Gates-funded journalism. 🧵Read on & RT:
19
500
971
0
16
22
@cpiller
Charles Piller
3 years
My latest deep dive in @sciencemagazine : “Failure to Protect?” Critics say “unconscionable” asthma study of mostly Black kids unethically withheld care, exploits inequalities—and they see a troubling trend.
4
17
22
@cpiller
Charles Piller
1 year
Hoping that our story, and this honor for it, will push the debate on how to detect and end apparent misconduct in key areas of Alzheimer's research.
Congratulations to the 2023 #NIHCM Trade Journalism Award winner for their in-depth investigation of possible fraud in a key area of Alzheimer's research. #NIHCMAwardsJournalism @cpiller @MeaganWeiland @NewsfromScience
Tweet media one
0
5
14
5
6
21
@cpiller
Charles Piller
2 years
Re: Steven Newmaster, something I still wonder about: Where did all the money go? He says says he never made a dime from his several companies despite millions in revenue. UG refused to release his disclosures. If anyone knows more, DM me. Thanks.
@cpiller
Charles Piller
2 years
My latest deep dive for @sciencemagazine : Botanist Steven Newmaster won scientific fame and business success with tests that purportedly showed herbal remedies didn’t contain the ingredients on their labels. Was it all based on fraud? 1/6
13
152
414
0
4
22
@cpiller
Charles Piller
7 years
Plaza filling up at #ScienceMarchSF
Tweet media one
0
12
18
@cpiller
Charles Piller
2 years
Excellent thread to see where things stand.
@MotherJones
Mother Jones
2 years
A lot has happened in the year since the Jan. 6 attack on the US Capitol. Let's take a look at some numbers. (Thread.)
Tweet media one
10
97
186
1
8
20
@cpiller
Charles Piller
3 years
Reporter prompts corrections in Nature, New York Times after researcher fails to disclose ties to Cargill - kudos to @TimothyWSchwab via @ivanoransky
0
4
20
@cpiller
Charles Piller
5 months
Looking for the details on possible image doctoring in papers by USC neuroscientist Berislav Zlokovic? My investigation for @newsfromscience links to a spreadsheet that lists many PubPeer pages with images recently posted by the whistleblowers.
3
9
20
@cpiller
Charles Piller
11 months
I hope the FDA Advisory Committee on lecanemab/Leqembi will get a close look at this thread, with its profound video of a case of severe brain bleeding associated with the drug.
@schrag_matthew
Matthew Schrag
11 months
I want to show you what microhemorrhages and brain swelling from anti-amyloid immunotherapies look like under a microscope. In this severe case, many of the vessels simply disintegrated - see the bleeding and numerous aneurysms in this striking image. #Alzheimer #lecanemab
12
73
201
2
6
19
@cpiller
Charles Piller
5 years
Science journalists: If you plan to be in Lausanne next week for #WCSJ2019 , consider checking out the “investigative methods for science journalism” panel I’ll be on, July 3 at 10:10am, with the illustrious @sarahemilywild @Newshawks @NordbeckAnna
0
8
18
@cpiller
Charles Piller
4 months
New, important expression of concern about a key paper described in my recent investigation of work by USC neuroscientist Berislav Zlokovic. My earlier article is here
2
8
18
@cpiller
Charles Piller
2 years
NIH continues to ignore its own clinical trial reporting rules, per new GAO report What will it take to get the agency to report reliably to ? I’ve reported on this multiple times, including 1/2
1
15
17
@cpiller
Charles Piller
3 years
How contradictory and strange has Buffett’s entire history in this realm been? Not very. His actions on corporate ethics, charity, tax equity, etc., were always in conflict with his saintly words, as I wrote in 2007.
@TimothyWSchwab
Tim Schwab
3 years
#WarrenBuffett just announced he is resigning as a trustee of #GatesFoundation , clearly distancing himself from an organization swimming (drowning?) in allegations of misconduct. 2 weeks ago in @thenation I raised questions about Buffett's continuing role
2
29
78
1
11
18